<SEC-DOCUMENT>0002007317-25-000875.txt : 20250814
<SEC-HEADER>0002007317-25-000875.hdr.sgml : 20250814
<ACCEPTANCE-DATETIME>20250814161021
ACCESSION NUMBER:		0002007317-25-000875
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250814
DATE AS OF CHANGE:		20250814

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amneal Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001723128
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-38485
		FILM NUMBER:		251219061

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		(908) 947-3120

	MAIL ADDRESS:	
		STREET 1:		400 CROSSING BOULEVARD
		STREET 2:		3RD FLOOR
		CITY:			BRIDGEWATER
		STATE:			NJ
		ZIP:			08807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Atlas Holdings, Inc.
		DATE OF NAME CHANGE:	20171117

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Shah Nikita
		CENTRAL INDEX KEY:			0001738061
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O AMNEAL PHARMACEUTICALS LLC
		STREET 2:		400 CROSSING BLVD
		CITY:			BRIDGEWATER
		STATE:			NJ
		ZIP:			08807
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001738061</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001723128</issuerCik>
      <issuerName>Amneal Pharmaceuticals, Inc.</issuerName>
      <secFileNumber>001-38485</secFileNumber>
      <issuerAddress>
        <com:street1> 400 CROSSING BLVD, THIRD FLOOR</com:street1>
        <com:city>BRIDGEWATER</com:city>
        <com:stateOrCountry>NJ</com:stateOrCountry>
        <com:zipCode>08807</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(908) 947-3120</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Shah Nikita</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>CLASS A</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>MERRILL LYNCH</name>
        <address>
          <com:street1>157 CHURCH ST, FL 26</com:street1>
          <com:city>NEW HAVEN</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06510</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>71694</noOfUnitsSold>
      <aggregateMarketValue>663065.00</aggregateMarketValue>
      <noOfUnitsOutstanding>314079309</noOfUnitsOutstanding>
      <approxSaleDate>08/14/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>CLASS A</securitiesClassTitle>
      <acquiredDate>02/27/2024</acquiredDate>
      <natureOfAcquisitionTransaction>EQUITY COMPENSATION</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>AMNEAL PHARMACEUTICALS</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>16950</amountOfSecuritiesAcquired>
      <paymentDate>02/27/2024</paymentDate>
      <natureOfPayment>EQUITY COMPENSATION</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>CLASS A</securitiesClassTitle>
      <acquiredDate>03/01/2024</acquiredDate>
      <natureOfAcquisitionTransaction>EQUITY COMPENSATION</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>AMNEAL PHARMACEUTICALS</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>13776</amountOfSecuritiesAcquired>
      <paymentDate>03/01/2024</paymentDate>
      <natureOfPayment>EQUITY COMPENSATION</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>CLASS A</securitiesClassTitle>
      <acquiredDate>03/03/2024</acquiredDate>
      <natureOfAcquisitionTransaction>EQUITY COMPENSATION</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>AMNEAL PHARMACEUTICALS</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>40968</amountOfSecuritiesAcquired>
      <paymentDate>03/03/2024</paymentDate>
      <natureOfPayment>EQUITY COMPENSATION</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>NIKITA SHAH</name>
        <address>
          <com:street1>400 CROSSING BLVD, THIRD FLOOR</com:street1>
          <com:city>BRIDGEWATER</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>08807</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>CLASS A</securitiesClassTitle>
      <saleDate>08/12/2025</saleDate>
      <amountOfSecuritiesSold>50000</amountOfSecuritiesSold>
      <grossProceeds>453000.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>NIKITA SHAH</name>
        <address>
          <com:street1>400 CROSSING BLVD</com:street1>
          <com:city>BRIDGEWATER</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>08807</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>CLASS A</securitiesClassTitle>
      <saleDate>05/16/2025</saleDate>
      <amountOfSecuritiesSold>49140</amountOfSecuritiesSold>
      <grossProceeds>370542.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>08/14/2025</noticeDate>
      <signature>NIKITA SHAH</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
